LifeStance Health Group, Inc. (LFST)

Market Cap	2.79B
Revenue (ttm)	1.21B
Net Income (ttm)	-95.29M
Shares Out	382.64M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	708.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,163,185
Open	6.95
Previous Close	7.05
Day's Range	6.92 - 7.34
52-Week Range	4.64 - 9.20
Beta	1.28
Analysts	Buy
Price Target	8.70 (+19.34%)
Earnings Date	Nov 7, 2024

About LFST

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder....

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Jun 10, 2021
• Employees: 9,325
• Stock Exchange: NASDAQ
• Ticker Symbol: LFST
• Website: https://lifestance.com

Financial Performance

In 2023, LifeStance Health Group's revenue was $1.06 billion, an increase of 22.82% compared to the previous year's $859.54 million. Losses were -$186.26 million, -13.59% less than in 2022.

Analyst Forecast

According to 5 analysts, the average rating for LFST stock is "Buy." The 12-month stock price forecast is $8.7, which is an increase of 19.34% from the latest price.

Price Target

$8.7

(19.34% upside)

Analyst Consensus: Buy